Izgi, K. Et Al. 2017. Current status in cancer cell reprogramming and its clinical implications. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.143, no.3 , 371-383.

Izgi, K., CANATAN, H., & Iskender, B., (2017). Current status in cancer cell reprogramming and its clinical implications. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.143, no.3, 371-383.

Izgi, Kenan, HALİT CANATAN, And BANU İSKENDER İZGİ. "Current status in cancer cell reprogramming and its clinical implications," JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.143, no.3, 371-383, 2017

Izgi, Kenan Et Al. "Current status in cancer cell reprogramming and its clinical implications." JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.143, no.3, pp.371-383, 2017

Izgi, K. CANATAN, H. And Iskender, B. (2017) . "Current status in cancer cell reprogramming and its clinical implications." JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY , vol.143, no.3, pp.371-383.

@article{article, author={Kenan Izgi Et Al. }, title={Current status in cancer cell reprogramming and its clinical implications}, journal={JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY}, year=2017, pages={371-383} }